These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5483974)

  • 41. Histochemical findings of fibrinolytic activities in the prostatic gland.
    Sugiura H; Shimaya M
    Invest Urol; 1970 Sep; 8(2):188-94. PubMed ID: 4099868
    [No Abstract]   [Full Text] [Related]  

  • 42. [Thrombolytic action of the tissue activator profibrinolysin and nicotinic acid].
    Andreenko GV; Migalina LA
    Vopr Med Khim; 1973; 19(4):371-4. PubMed ID: 4788286
    [No Abstract]   [Full Text] [Related]  

  • 43. Fibrinolytic activity in blood and lungs of rats treated with monocrotaline pyrrole.
    Schultze AE; Roth RA
    Toxicol Appl Pharmacol; 1993 Jul; 121(1):129-37. PubMed ID: 7687795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibrinogen turnover during the treatment with xantinol nicotinate.
    Cultrera G; Giarola P; Gibelli A; Baldoni E; Cuttin S; Galetti G; Serenth'a P
    Arzneimittelforschung; 1971 Jul; 21(7):954-7. PubMed ID: 5109508
    [No Abstract]   [Full Text] [Related]  

  • 45. A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) - part II: enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosis.
    Wang YX; da Cunha V; Vincelette J; Zhao L; Nagashima M; Kawai K; Yuan S; Emayan K; Islam I; Hosoya J; Sullivan ME; Dole WP; Morser J; Buckman BO; Vergona R
    Thromb Haemost; 2007 Jan; 97(1):54-61. PubMed ID: 17200771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro studies of staphylokinase.
    Sweet B; McNicol GP; Douglas AS
    Clin Sci; 1965 Oct; 29(2):375-82. PubMed ID: 5840981
    [No Abstract]   [Full Text] [Related]  

  • 47. [Fibrinolysis in myocardial infarction with EKG elevation. Optimization of myocardial reperfusion by treatment with antithrombotic agents].
    Jaïs C; Coste P; Labèque JN; Perron JM; Lafitte S; Zabsonré P; Roudaut R
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1259-66. PubMed ID: 11794967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet activation by fibrinolytic agents: a potential mechanism for resistance to thrombolysis and reocclusion after successful thrombolysis.
    Leopold JA; Loscalzo J
    Coron Artery Dis; 1995 Dec; 6(12):923-9. PubMed ID: 8723013
    [No Abstract]   [Full Text] [Related]  

  • 49. Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor.
    Minnema MC; Friederich PW; Levi M; von dem Borne PA; Mosnier LO; Meijers JC; Biemond BJ; Hack CE; Bouma BN; ten Cate H
    J Clin Invest; 1998 Jan; 101(1):10-4. PubMed ID: 9421460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pharmacological potentials for activating the fibrinolytic system].
    Markwardt F
    Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities.
    Fonseca RJ; Oliveira SN; Melo FR; Pereira MG; Benevides NM; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):539-45. PubMed ID: 18327402
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo.
    Ueshima S; Matsuno H; Hayashi M; Horibuchi K; Okada K; Fukao H; Uematsu T; Matsuo O
    Thromb Haemost; 2002 Jun; 87(6):1069-74. PubMed ID: 12083488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigations on the action of pethidine during increased fibrinolytic acitivity in the blood of rats.
    Malinowska L
    Anaesth Resusc Intensive Ther; 1974; 2(2):113-21. PubMed ID: 4455100
    [No Abstract]   [Full Text] [Related]  

  • 54. Formation of hyaline microthrombi in the mouse. Evidence for dependence on the fibrinolytic system.
    Skjorten F; Kierulf PB; Degré M
    Acta Pathol Microbiol Scand A; 1970; 78(3):351-61. PubMed ID: 5507260
    [No Abstract]   [Full Text] [Related]  

  • 55. Vascular cell-derived fibrinolytic regulators and atherothrombotic vascular disorders (Review).
    Shen GX
    Int J Mol Med; 1998 Feb; 1(2):399-408. PubMed ID: 9852242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacology of fibrinolytic agents.
    Barlow GH
    Prog Cardiovasc Dis; 1979; 21(5):315-26. PubMed ID: 368881
    [No Abstract]   [Full Text] [Related]  

  • 57. [Leukocytes and fibrinolysis. II. Study of pathological leukocytes].
    Tatarsky I; Sinakos Z; Larrieu MJ; Bernard J
    Nouv Rev Fr Hematol; 1967; 7(1):95-107. PubMed ID: 4226638
    [No Abstract]   [Full Text] [Related]  

  • 58. [Fibrinolysis by nicotinic acid derivatives].
    Thies HA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(2):216-9. PubMed ID: 4106011
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacology of thrombolytic agents. Implications for therapy of coronary artery thrombosis.
    Marder VJ
    Circulation; 1983 Aug; 68(2 Pt 2):I2-5. PubMed ID: 6683134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Fibrinolytic and thrombolytic properties of a plasminogen activator isolated from the culture broth of calf kidney cells].
    Egorov BB; Andreenko GV; Liaginskiĭ AV; Stelingovskií KV; Podorol'skaia LV
    Farmakol Toksikol; 1983; 46(4):54-6. PubMed ID: 6684592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.